Bio-Techne
TECH
#1479
Rank
โ‚ฌ11.18 B
Marketcap
70,36ย โ‚ฌ
Share price
-0.50%
Change (1 day)
32.01%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) Fails to deliver data

Key failure to deliver metrics for Bio-Techne:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Bio-Techne (TECH) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Bio-Techne (TECH) - since 2014

Volume in USD (price x number of shares), data since 2014

Bio-Techne (TECH) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024โ‚ฌ26.94 M-37%
2023โ‚ฌ42.76 M-15.62%
2022โ‚ฌ50.68 M-42.56%
2021โ‚ฌ88.22 M200.19%
2020โ‚ฌ29.39 M124.27%
2019โ‚ฌ13.1 M90.7%
2018โ‚ฌ6.87 M-5.05%
2017โ‚ฌ7.23 M-54.94%
2016โ‚ฌ16.06 M17.78%
2015โ‚ฌ13.63 M342.13%
2014โ‚ฌ3.08 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
โ‚ฌ34.32 Mโ‚ฌ0.29 B๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ7.12 Mโ‚ฌ16.05 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ30.88 Mโ‚ฌ93.63 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.14 Bโ‚ฌ0.25 B๐Ÿ‡บ๐Ÿ‡ธ USA
N/Aโ‚ฌ5.06 M๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
โ‚ฌ0.28 Bโ‚ฌ1.28 B๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0 Mโ‚ฌ0.06 M๐Ÿ‡บ๐Ÿ‡ธ USA